Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04369053 · ClinicalTrials.gov registry record
Prevention of Colorectal Cancer Through Multiomics Blood Testing
A clinical trial, sponsored by Freenome Holdings.
- Completed
- Registry status
- 48,995
- Enrollment target
NCT04369053 is a clinical trial that has completed, run by Freenome Holdings. The registered enrollment target is 48,995 participants.
The verdict
NCT04369053 has completed, sponsored by Freenome Holdings.
- COMPLETED
- Registry status
- 48,995 participants
- Enrollment target
Study Summary
The PREEMPT CRC study is a prospective multi-center observational study to validate a blood-based test for the early detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy.
Interventions
- DIAGNOSTIC_TEST Freenome test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48,995 participants |
| Start Date | 2020-05-20 |
| Est. Completion | 2024-02-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04369053
The ClinicalTrials.gov registry entry for NCT04369053 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 48,995 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Freenome Holdings, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Freenome test is the first listed.
NCT04369053 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04369053 about?
NCT04369053 is a clinical study titled "Prevention of Colorectal Cancer Through Multiomics Blood Testing". The PREEMPT CRC study is a prospective multi-center observational study to validate a blood-based test for the early detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy.
What is the current status of trial NCT04369053?
This trial is currently completed. The enrollment target is 48,995 participants. The study started on 2020-05-20. Estimated completion is 2024-02-29.
What interventions are being tested in trial NCT04369053?
The interventions under investigation include: Freenome test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04369053?
This trial is sponsored by Freenome Holdings, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.